Scans found signs of nerve connection loss in MS and mice
By MS Buddy ·
Summarized from Proceedings of the National Academy of Sciences of the United States of America, Mar 2026 · PubMed · DOI. AI-generated summary. Not medical advice.
Observational study · 12 people with and without MS, plus mice with an MS-like disease
Research by Pou Hong Justin Chia, Chao Zheng and 12 colleagues at Yale University, Campbell Family Mental Health Research Institute and 1 other institution in the United States, Canada and Finland.
Can brain scans detect signs of nerve connection loss in people with MS?
Key Takeaway
Brain scans found signs of fewer connections between nerve cells in people with MS and in mice with an MS-like disease.

What They Found
Researchers used a brain scan to look for signs of connections between nerve cells. In mice with an MS-like disease, the scan signal was nearly 30% lower across the brain regions studied. Other lab tests supported the mouse scan findings and found lower levels of the same marker in the spinal cord. In people with MS, the scan signal was about 16% lower across the brain’s outer layer than in people without MS. Several brain areas showed reductions of about 16% to 26%.
Who Should Care and Why
The study included mice with an MS-like disease and people with and without MS. The people with MS were compared with people without MS of similar ages. The researchers studied a scan that may help measure the loss of connections between nerve cells. They found similar patterns of loss in the mice and the people with MS. The human results came from a small early study.
Important Considerations
You should know the human study compared 6 people with MS and 6 people without MS. It did not test a treatment. The abstract does not say whether these scan results can predict changes in your symptoms or disability.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Proceedings of the National Academy of Sciences of the United States of America by et al.. Reproduced from the PubMed record.
Synaptic loss is increasingly recognized as a key pathological feature in multiple sclerosis (MS), contributing to disease progression and cognitive dysfunction. Synaptic vesicle glycoprotein 2A (SV2A) positron emission tomography (PET) imaging has emerged as a promising tool for quantifying synaptic density in vivo. Here, we used the clinically translatable tracer [F]SynVesT-1 to comprehensively characterize synaptic density across the brain and spinal cord in the experimental autoimmune encephalomyelitis (EAE) mouse model of MS. In parallel, we performed SV2A PET in patients with MS using the first clinically implemented SV2A radiotracer, [C]UCB-J, providing cross-species validation of SV2A PET imaging as a biomarker of synaptic pathology. In EAE mice, dynamic [F]SynVesT-1 PET imaging revealed a significant global reduction in tracer uptake, with nearly 30% decrease in regional distribution volume () across all analyzed brain regions ( < 0.0001). Correspondingly, autoradiography (ARG) corroborated the PET findings, and additional analyses demonstrated reduced SV2A levels in the cervical and lumbar spinal cord. In a clinical PET research study, [C]UCB-J imaging in MS patients (n = 6) versus age-matched healthy controls (n = 6) showed a 16.4% reduction in global cortical SV2A binding ( = 0.026), with significant regional reductions of 16 to 26% in several cortical and subcortical subregions. Together, these findings demonstrate that SV2A PET imaging provides a sensitive and quantitative biomarker of synaptic pathology in MS. The consistent reductions in SV2A binding observed in both preclinical and clinical research highlight the role of synaptic degeneration in MS and underscore the utility of SV2A PET imaging in MS research.
Categories
Explore more research
Related MS research

11/16/2026
A planned study will use detailed brain scans and blood tests to explore why relapsing-remitting MS
Read More
1/1/2026
After a car crash, brain and spine scans revealed signs of MS in an 18-year-old male. Further tests
Read More
11/14/2026
An opinion paper explains why MS brain scans can show tissue loss without proving nerve signal failu
Read More
11/15/2026
In tissue from mice with an MS-like disease, a lab drug reduced excess chemical release from nerve e
Read More
11/15/2026
In 70 people with MS in Brazil, blood tests often showed signs of past viral exposure. Results did n
Read More
11/13/2026
A review compares MS with harmful drug reactions and proposes ways to test how immune genes, lasting
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
